An interventional study of Effective oxygen delivery and lung expansion measurement in Respiratory Distress Syndrome (Neonatal) and Respiratory Distress of Newborn, sponsored by University of Arkansas. Recruiting at 2 sites in United States. Per ClinicalTrials.gov, last updated 2026-06-30.
Sponsored by University of Arkansas · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 43 studies in Pulmonary Atelectasis with a site in United States — 11 open to participants now, 11 under way, 1 of them phase 3. Pulmonary Atelectasis · United States.
Among the 43 studies in Pulmonary Atelectasis with a site in United States, this one is the 33rd largest by planned enrollment of the 37 interventional ones that give a count, is one of 4 that started in 2026, is one of 31 with no phase, reaches primary completion later than 2 of the 10 other live ones, and was the 43rd registered.
378 studies on the registry are indexed under Pulmonary Atelectasis; 91 are open to participants now.
Browse Pulmonary Atelectasis studies →11 of the 43 studies in Pulmonary Atelectasis with a site in United States are open now. Recruiting first, the newest first:
University of Texas Southwestern Medical Center · Sites in United States
Ages 0 hrs–72 hrs
University of Texas Southwestern Medical Center · Sites in United States
Ages 0 hrs–3 days
Hackensack Meridian Health · Sites in United States
Ages 34 wk–36 wk
ONY · Sites in United States
Ages 29 wk–36 wk
NYU Langone Health · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 51 Pulmonary Atelectasis studies recruiting now, 20 (39%) set no upper age limit and 23 (45%) stop at 75 or younger; 24 take children under 18; 2 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
43 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 3 · Phase 3 2 · Phase 4 1
First in 2005; this study’s year is marked. 4 started in 2026.
This study's planned enrollment of 10 is below the median of 60 across 268 interventional studies indexed under Pulmonary Atelectasis.
Median enrollment 40 across the 37 interventional studies, 300 across the 5 observational. Of the 26 that completed or were terminated, 13 (50%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 43 have an industry lead sponsor. The 10 most frequent:
University of Arkansas is the lead sponsor of 399 studies on the registry; 38 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 35 (95%) have results posted.
University of Arkansas has 1 study filed under Pulmonary Atelectasis — fewer than ten, so there is no comparison to draw.
5 of the studies in Pulmonary Atelectasis with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06538376Brigham and Women's HospitalClinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU | 2026-11 |
| NCT07674953University of ArkansasHow Different Levels of CPAP Affect Oxygen Delivery and Lung Expansion in Preterm Infants | 2026-12 |
| NCT05675345NYU Langone HealthPhysiological Effects of Continuous Negative External Pressure for Acute Hypoxemic Respiratory Failure | 2027-06-30 |
| NCT07418502University of Texas at AustinPressure Targeting During High Flow Therapy in Premature Infants | 2027-08 |
| NCT07216053Hackensack Meridian HealthPredictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates | 2027-11 |
Add all 5 to your calendar (.ics) → With an account.
Among the 43 studies in Pulmonary Atelectasis with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
With this study, it is expected to learn more about preterm babies on breathing support with nasal continuous positive airway pressure (nCPAP). To gain more information on how much oxygen is actually delivered to the baby from the nCPAP machine.
This study will tell more about a specific method of breathing support used frequently with preterm babies called nasal continuous positive airway pressure (nCPAP). It helps the baby breathe by providing air pressure and a certain amount of oxygen. It is very important for the baby's health to provide only as much oxygen as they need.
With this study, it is expected to learn if the amount of oxygen ordered by a doctor on the nCPAP machine changes when it reaches the baby's airway, and if the amount of oxygen changes depending on how much air pressure the doctor provides. The answers to these questions, are not known, because special measurements are required that are difficult to know while a baby is on nCPAP. This study will collect these special measurements
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All infants on CPAP will have a catheter placed in their oropharynx to measure delivered oxygen and a soft band placed around the infant's chest to measure lung expansion.
Device: Effective oxygen delivery and lung expansion measurement
This intervention arm will involve any infant who is already on nCPAP. It will involve placing a catheter in the infant's oropharynx and wrapping soft EIT bands around the infants chest to measure effective oxygen delivery and lung expansion, respectively.
Also known as: EIT
Inspired Oxygen
Percent of oxygen delivered to the back of the infant's mouth. This will be measured by placing a small plastic tube in the back of the infant's mouth and sampling the air while the infant is receiving several different pressure levels of CPAP.
Time frame: Sampling will occur at three separate points within a thirty minute time frame for each enrolled infant.
Lung Volume
Using Electrical Impedance Tomography bands, the infant's lung volume will be monitored at several different CPAP pressure levels. These bands wrap around the infant's chest and measure lung volume using mild electrical currents.
Time frame: Long volume will be continuously monitored throughout the 30 minute duration of the study for each enrolled infant.
Plan to share: Yes — Coded IPD will be shared with a collaborator once data collection is complete for the purpose of statistical analysis. All shared IPD will be de-identified and individual patients will be given an identifying code. Shared information will include gestational age, date of birth, postnatal age, race/ethnicity, vital signs, prior medical history, current respiratory support, complications during pregnancy, medical problems and diagnoses that the infant receives during hospitalization, and the inspired oxygen and lung volume values gathered during the study itself.
Time frame: Beginning once data collection is complete and for three months afterward to afford time for statistical analysis.
Access criteria: Only primary investigators will be able to access de-coded IPD. One single collaborator will have access to coded IPD for the purpose of statistical analysis.
Started Apr 2026 (actual). Primary completion is estimated for Dec 2026, 8 months after the start.
Of 155 non-industry interventional studies with no phase under Pulmonary Atelectasis, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 8 months is below that.
Counting every sponsor, half of 157 studies reached it within 11 months; a quarter within 5 and three quarters within 21.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.